Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -35.78% | 2.65% | |||
| Depreciation & Amortization | 1.83% | -3.33% | |||
| Other Operating Expenses | 255.22% | 192.41% | |||
| Total Operating Expenses | -3.97% | 24.19% | |||
| Operating Income | 7.93% | -24.19% | |||
| Income Before Tax | 7.90% | -24.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.90% | -24.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -27.54% | 72.16% | |||
| Net Income | 5.56% | -20.19% | |||
| EBIT | 7.93% | -24.19% | |||
| EBITDA | 9.57% | -30.25% | |||
| EPS Basic | 21.05% | 0.00% | |||
| Normalized Basic EPS | 18.18% | 0.00% | |||
| EPS Diluted | 21.05% | 0.00% | |||
| Normalized Diluted EPS | 18.18% | 0.00% | |||
| Average Basic Shares Outstanding | 15.48% | 23.41% | |||
| Average Diluted Shares Outstanding | 15.48% | 23.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||